Beth A. Lopour

Beth A. Lopour

Auto-generated profile, based on publicly available information

Beth A. Lopour

University of California, Irvine

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
KSKavyakantha Remakanthakurup Sindhu
Kavyakantha Remakanthakurup Sindhu
RSRichard Staba
Richard Staba
BLBeth A. Lopour
Beth A. Lopour

1 October 2018 in Clinical Neurophysiology
Verified
Journal Article
Closed access
DSDaniel W. Shrey
Daniel W. Shrey
OMOlivia Kim McManus
Olivia Kim McManus
RRRajsekar Rajaraman
Rajsekar Rajaraman
HOHernando Ombao
Hernando Ombao
SHShaun A. Hussain
Shaun A. Hussain
BLBeth A. Lopour
Beth A. Lopour

1 October 2021 in Epilepsy Research
Verified
Journal Article
Open access
RSRachel June Smith
Rachel June Smith
DHDerek K. Hu
Derek K. Hu
DSDaniel W. Shrey
Daniel W. Shrey
RRRajsekar Rajaraman
Rajsekar Rajaraman
SHShaun A. Hussain
Shaun A. Hussain
BLBeth A. Lopour
Beth A. Lopour
Favorable neurodevelopmental outcomes in epileptic spasms (ES) are tied to early diagnosis and prompt treatment, but uncertainty in the identification of the disease can delay this process. Therefore, we investigated five categories of computational electroencephalographic (EEG) measures as markers of ES. We measured 1) amplitude, 2) power spectra, 3) Shannon entropy and permutation entropy, 4) long-range temporal correlations, via detrended fluctuation analysis (DFA) and 5) functional connectivity using cross-correlation and phase lag index (PLI). EEG data were analyzed from ES patients (n = 40 patients) and healthy controls (n = 20 subjects), with multiple blinded measurements during wakefulness and sleep for each patient. In ES patients, EEG amplitude was significantly higher in all electrodes when compared to controls. Shannon and permutation entropy were lower in ES patients than control subjects. The DFA intercept values in ES patients were significantly higher than control subjects, while DFA exponent values were not significantly different between the groups. EEG functional connectivity networks in ES patients were significantly stronger than controls when based on both cross-correlation and PLI. Significance for all statistical tests was p < 0.05, adjusted for multiple comparisons using the Benjamini-Hochberg procedure as appropriate. Finally, using logistic regression, a multi-attribute classifier was derived that accurately distinguished cases from controls (area under curve of 0.96). Computational EEG features successfully distinguish ES patients from controls in a large, blinded study. These objective EEG markers, in combination with other clinical factors, may speed the diagnosis and treatment of the disease, thereby improving long-term outcomes.

28 July 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
BMBlanca Romero Milà
Blanca Romero Milà
KSKavyakantha Remakanthakurup Sindhu
Kavyakantha Remakanthakurup Sindhu
JMJohn R. Mytinger
John R. Mytinger
DSDaniel W. Shrey
Daniel W. Shrey
BLBeth A. Lopour
Beth A. Lopour
Early diagnosis and treatment are critical for young children with infantile spasms (IS), as this maximizes the possibility of the best possible child-specific outcome. However, there are major barriers to achieving this, including high rates of misdiagnosis or failure to recognize the seizures, medication failure, and relapse. There are currently no validated tools to aid clinicians in assessing objective diagnostic criteria, predicting or measuring medication response, or predicting the likelihood of relapse. However, the pivotal role of EEG in the clinical management of IS has prompted many recent studies of potential EEG biomarkers of the disease. These include both visual EEG biomarkers based on human visual interpretation of the EEG and computational EEG biomarkers in which computers calculate quantitative features of the EEG. Here, we review the literature on both types of biomarkers, organized based on the application (diagnosis, treatment response, prediction, etc.). Visual biomarkers include the assessment of hypsarrhythmia, epileptiform discharges, fast oscillations, and the Burden of AmplitudeS and Epileptiform Discharges (BASED) score. Computational markers include EEG amplitude and power spectrum, entropy, functional connectivity, high frequency oscillations (HFOs), long-range temporal correlations, and phase-amplitude coupling. We also introduce each of the computational measures and provide representative examples. Finally, we highlight remaining gaps in the literature, describe practical guidelines for future biomarker discovery and validation studies, and discuss remaining roadblocks to clinical implementation, with the goal of facilitating future work in this critical area.

1 November 2020 in Clinical Neurophysiology
Verified
Journal Article
Closed access
KCKrit Charupanit
Krit Charupanit
ISIndranil Sen-Gupta
Indranil Sen-Gupta
JLJack J. Lin
Jack J. Lin
BLBeth A. Lopour
Beth A. Lopour

26 July 2017 in Brain Topography
Verified
Journal Article
Closed access
PDF file
KCKrit Charupanit
Krit Charupanit
BLB. A. Lopour
B. A. Lopour